Sapphire Bioscience Holding ApS — Credit Rating and Financial Key Figures
CVR number: 38599917
Industriparken 39, 2750 Ballerup
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 108 874.00 | 136 234.00 | 137 367.00 | ||
| Employee benefit expenses | -44 010.00 | -56 002.00 | -78 790.00 | ||
| Total depreciation | -16 746.00 | -22 628.00 | -17 535.00 | ||
| EBIT | 48 118.00 | 57 604.00 | 41 042.00 | ||
| Other financial income | 3 057.00 | 4 947.00 | |||
| Other financial expenses | - 925.00 | -1 109.00 | -6 633.00 | ||
| Pre-tax profit | 24 389.00 | 25 843.00 | 47 193.00 | 59 552.00 | 39 356.00 |
| Income taxes | -9 253.00 | -12 868.00 | -10 892.00 | ||
| Net earnings | 24 389.00 | 25 843.00 | 37 940.00 | 46 684.00 | 28 464.00 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Development expenditure | 47 450.00 | 41 316.00 | 44 742.00 | |
| Intangible rights | 401.00 | 771.00 | 570.00 | |
| Intangible assets total | 47 851.00 | 42 087.00 | 45 312.00 | |
| Land and waters | 24 011.00 | 24 090.00 | ||
| Buildings | 3 076.00 | 3 303.00 | 6 021.00 | |
| Machinery and equipment | 4 959.00 | 2 212.00 | 2 233.00 | |
| Tangible assets total | 32 046.00 | 29 605.00 | 8 254.00 | |
| Other non-current investments | 809.00 | 922.00 | 1 086.00 | |
| Investments total | 1 520.00 | 2 096.00 | 4 671.00 | |
| Long term receivables total | ||||
| Semifinished products | 8 070.00 | 6 020.00 | 8 892.00 | |
| Raw materials and consumables | 18 516.00 | 27 354.00 | 32 666.00 | |
| Finished products/goods | 15 710.00 | 27 952.00 | 28 931.00 | |
| Advance payments | 214.00 | |||
| Inventories total | 42 510.00 | 61 326.00 | 70 489.00 | |
| Current trade debtors | 20 397.00 | 43 894.00 | 43 599.00 | |
| Prepayments and accrued income | 1 597.00 | 3 586.00 | 3 346.00 | |
| Current other receivables | 2 509.00 | 1 873.00 | 1 930.00 | |
| Current deferred tax assets | 2 963.00 | 172.00 | 1 025.00 | |
| Short term receivables total | 27 466.00 | 49 525.00 | 49 900.00 | |
| Cash and bank deposits | 14 513.00 | 48 360.00 | 49 244.00 | 43 983.00 |
| Cash and cash equivalents | 14 513.00 | 48 360.00 | 49 244.00 | 43 983.00 |
| Balance sheet total (assets) | 14 513.00 | 199 753.00 | 233 883.00 | 222 609.00 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 88 745.00 | 98 630.00 | 15 878.00 | 15 878.00 | 15 878.00 |
| Shares repurchased | 31 755.00 | ||||
| Other reserves | 25 488.00 | 29 251.00 | 64 239.00 | ||
| Retained earnings | -24 389.00 | -25 843.00 | 58 076.00 | 60 666.00 | 41 495.00 |
| Profit of the financial year | 24 389.00 | 25 843.00 | 37 940.00 | 46 684.00 | 28 464.00 |
| Shareholders equity total | 88 745.00 | 98 630.00 | 137 382.00 | 184 234.00 | 150 076.00 |
| Provisions | 624.00 | 5 652.00 | 10 053.00 | ||
| Non-current loans from credit institutions | 463.00 | 263.00 | 88.00 | ||
| Non-current liabilities total | 463.00 | 263.00 | 88.00 | ||
| Current loans from credit institutions | 15 445.00 | 1 423.00 | |||
| Advances received | 21 047.00 | 20 772.00 | 34 248.00 | ||
| Current trade creditors | 13 742.00 | 11 458.00 | 10 892.00 | ||
| Short-term deferred tax liabilities | 2 716.00 | 225.00 | 2 023.00 | ||
| Other non-interest bearing current liabilities | 8 334.00 | 9 856.00 | 15 229.00 | ||
| Current liabilities total | 61 284.00 | 43 734.00 | 62 392.00 | ||
| Balance sheet total (liabilities) | 88 745.00 | 98 630.00 | 199 753.00 | 233 883.00 | 222 609.00 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.